Centene Corp logo

Centene Corp

NEW
NYSE:CNC (USA)   Ordinary Shares
$ 63.41 -0.33 (-0.52%) 10:08 PM EST
On watch
At Loss
P/B:
1.46
Market Cap:
$ 31.31B
Enterprise V:
$ 24.04B
Volume:
2.76M
Avg Vol (2M):
4.99M
Warning! GuruFocus detected 1 Severe warning sign with CNC. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
2.76M
Market Cap $:
31.31B
At Loss
Avg Vol (2M):
4.99M
Enterprise Value $:
24.04B
PB Ratio:
1.46
What is a stock summary page? Click here for an overview. Powered by GuruAPI
Website SEC Filings Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocks™

Business Description

Centene Corp logo
Centene Corp
NAICS : 524114 SIC : 6324
ISIN : US15135B1017
https://www.centene.com
7700 Forsyth Boulevard, St. Louis, MO, USA, 63105

Share Class Description:

CNC: Ordinary Shares

Total Employee Number:

61,100
Compare
Compare
HUMMOHOSCRALHCCLOVPGNYPFHOCIELVCVSUNHBSP:SAUD3SZSE:000503NSE:MEDIASSISTBJSE:920656BSP:QUAL3ROCO:6665
Traded in other countries / regions
CNC.USA0HVB.UKQEN.Germany1CNC.ItalyC1NC34.BrazilCNC.Mexico
Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index
IPO Date
2001-12-13
Description
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt
 1.45
Equity-to-Asset
 0.26
Debt-to-Equity
 0.76
Debt-to-EBITDA
 -3.69
Interest Coverage
 0.02
Piotroski F-Score
 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
 2.77
Distress
Grey
Safe
Beneish M-Score
 -2.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

2/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
 16.7
3-Year EPS without NRI Growth Rate
 -28.9
3-Year FCF Growth Rate
 -1
3-Year Book Growth Rate
 -2.4
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank
 41.78

Momentum Rank

6/10
Name Current Vs Industry Vs History
5-Day RSI
 32.03
9-Day RSI
 40.22
14-Day RSI
 45.89
3-1 Month Momentum %
 50.57
6-1 Month Momentum %
 36.62
12-1 Month Momentum %
 135.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
 1.12
Quick Ratio
 1.12
Cash Ratio
 0.59
Days Sales Outstanding
 38.56
Days Payable
 29.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
 3.7
Shareholder Yield %
 3.96

Profitability Rank

7/10
Name Current Vs Industry Vs History
Gross Margin %
 7.18
Operating Margin %
 0.01
Net Margin %
 -3.25
EBITDA Margin %
 -2.24
FCF Margin %
 3.59
OCF Margin %
 4.01
ROE %
 -27.39
ROA %
 -7.79
ROIC %
 0.02
3-Year ROIIC %
 39.8
ROC (Joel Greenblatt) %
 -264.74
ROCE %
 -12.84
Years of Profitability over Past 10-Year
 9
Moat Score
 7
Tariff Resilience Score
 7

GF Value Rank

8/10
Name Current Vs Industry Vs History
Forward PE Ratio
 18.03
PE Ratio without NRI
 50.65
Shiller PE Ratio
 27.93
PS Ratio
 0.16
PB Ratio
 1.46
Price-to-Tangible-Book
 5.03
Price-to-Free-Cash-Flow
 4.43
Price-to-Operating-Cash-Flow
 3.9
EV-to-EBIT
 -4.22
EV-to-Forward-EBIT
 23.04
EV-to-EBITDA
 -5.41
EV-to-Forward-EBITDA
 11.87
EV-to-Revenue
 0.12
EV-to-Forward-Revenue
 0.13
EV-to-FCF
 3.38
Price-to-GF-Value
 0.76
Price-to-Projected-FCF
 0.41
Price-to-Median-PS-Value
 0.49
Price-to-Graham-Number
 3.36
Earnings Yield (Greenblatt) %
 -23.7
FCF Yield %
 22.71
Forward Rate of Return (Yacktman) %
 23.45

Financials (Next Earnings Date:2026-07-28)

CNC's 30-Y Financials
AAPL
Income Statement Breakdown FY
Not Enough Data
AAPL
Balance Sheet Breakdown
Not Enough Data
AAPL
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Centene Corp Operating Data

CNC's Complete Operating Data
No operating data available for Centene Corp.

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:CNC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Centene Corp Executives

Details

GF Value™: $83.23

CNC

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 198,101
EPS (TTM) ($) -13.14
Beta 1.5821
3-Year Sharpe Ratio 0.19
3-Year Sortino Ratio 0.3
Volatility % 94.76
14-Day RSI 45.89
14-Day ATR ($) 2.405497
20-Day SMA ($) 66.265
12-1 Month Momentum % 135.31
52-Week Range ($) 25.075 - 69.355
Shares Outstanding (Mil) 493.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Centene Corp Filings

Filing Date Document Date Form
No Filing Data

Centene Corp Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings conference call for 2026 2026-10-27 08:30 In 95 days
Third quarter earnings results for 2026 2026-10-27 In 94 days
Second quarter earnings conference call for 2026 2026-07-28 08:30 In 4 days
Second quarter earnings results for 2026 2026-07-28 06:00 In 4 days
General meeting for 2026 2026-05-12 10:00 56.36 (-0.16%)
First quarter earnings conference call for 2026 2026-04-28 08:30 43.50 (+4.12%)
First quarter earnings results for 2026 2026-04-28 06:00 43.50 (+4.12%)
Annual report for 2025 2026-02-17 40.58 (+4.45%)
Fourth quarter earnings conference call for 2025 2026-02-06 09:00 39.92 (-1.82%)
Fourth quarter earnings results for 2025 2026-02-06 06:00 39.92 (-1.82%)
Show
Entries
  • 1
  • 2
  • 3
  • 4

Centene Corp Frequently Asked Questions

What is Centene Corp(CNC)'s stock price today?
The current price of CNC is $63.41. The 52 week high of CNC is $69.36 and 52 week low is $25.08.
When is next earnings date of Centene Corp(CNC)?
The next earnings date of Centene Corp(CNC) is 2026-07-28.
Does Centene Corp(CNC) pay dividends? If so, how much?
Centene Corp(CNC) does not pay dividend.

Guru Commentaries on NYSE:CNC

Centene is one of the largest health insurers in the U.S. The company specializes in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage, each of which benefits from long-term secular tailwinds. In Medicaid, states are steadily outsourcing their programs to companies like Centene to reduce costs and improve care quality. Managed Medicaid penetration has increased throughout the past decade and we expect further gains over time. In Marketplace, growth is driven by the trend toward more individuals buying health insurance. Centene holds the #1 market share in both of these programs and is well positioned to capitalize on their continued growth. Finally, we believe management is successfully turning around Centene’s Medicare business and expect the division to generate positive earnings over time. After adjusting for losses stemming from Centene's Medicare business, we were able to purchase shares at a single-digit P/E multiple, which we think is too cheap for a leading, secularly growing Medicaid company and an improving Medicare business.
Bill Nygren (Trades, Portfolio), Oakmark Select Fund, Q2 2024 Fund Letter
Centene is a large health insurer specializing in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage. Each of these programs benefits from long-term secular tailwinds. In Medicaid, states are steadily outsourcing their programs to managed care companies like Centene to help reduce costs and improve care quality. Managed Medicaid penetration has increased meaningfully over the past two decades, and we expect further gains over time. In Marketplace, growth is driven by the trend toward more individuals buying health insurance. Centene holds the top market share in both of these programs and is well-positioned to capitalize on their continued growth. Finally, in Centene’s Medicare Advantage business, past missteps will result in losses next year, but we believe Centene can turn its Medicare Advantage segment around and generate positive earnings in the next few years. Centene currently trades for about 9x our estimate of normal earnings power, which we believe is a compelling value for a business that generates healthy returns on capital and is capable of growing EPS at a low double-digit rate.
David Herro (Trades, Portfolio), Oakmark Global Select Fund, Q1 2024 Fund Letter

Press Release

Subject Date
CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL 2026-07-10
CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT 2026-07-09
Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles 2026-06-23
CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS 2026-06-22
Modesto Residents Will Gain Access to More Affordable Homes Due to $4 Million Health Net Investment 2026-06-18
MHS Launches Statewide Program to Help Indiana Medicaid Members with Employment 2026-06-16
Superior HealthPlan Recognized as a Best Place for Working Parents® in Texas 2026-06-16
Home State Health, Centene Foundation Announce $750,000 Grant Opportunity for Missouri Organizations Improving Health Outcomes 2026-06-10
Long Beach Community Care Campus Expansion Advances with $10 Million Investment from Centene Foundation and Health Net 2026-06-10
Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit 2026-05-12
10/Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 84

Articles on Centene Corp

Article Image
Article Image
Article Image
Article Image
Article Image

Headlines

See More
  • 1
Jul 23, 2026
Molina tumbles despite Q2 beat amid high medical expenses
Seeking Alpha • 9:27am
Jul 22, 2026
US defers more than $1B in Medicaid payments to California, Minnesota
Seeking Alpha • 12:27am
Jul 17, 2026
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2
Seeking Alpha • 8:35am
Jul 16, 2026
UnitedHealth lifts managed care peers after guidance hike
Seeking Alpha • 5:31am
Jul 15, 2026
Molina, Centene, and Oscar are down after Elevance Health’s Q2 report
Seeking Alpha • 6:08am
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文
Education
Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2026 GuruFocus.com, LLC. All Rights Reserved.